Bristol-Myers Squibb and Pfizer announced that the FDA has accepted for review a supplemental New Drug Application (sNDA) for Eliquis (apixaban), for prophylaxis of deep vein thrombosis (DVT), which ...

Eliquis is prescribed to treat or prevent blood clots and to reduce the risk of stroke in certain adults. Its dosage varies based on the condition being treated and other factors. The standard Eliquis ...

The Food and Drug Administration has approved two applications for the first generics of Bristol-Myers Squibb's Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in ...

Eliquis (apixaban) is a prescription oral tablet used to reduce the risk of stroke in certain adults and to treat or prevent blood clots in certain adults and children. The Eliquis dosage you’re ...